Cargando…

Bioconjugated materials. Part 2, Applications in drug delivery, vaccine formulations and important conjugates for cancer therapy /

Bioconjugated Materials Part 2, Volume 103 in the Comprehensive Analytical Chemistry series, highlights new advances in the field, with this new volume presenting interesting chapters on bioconjugated materials. Each chapter is written by an international board of authors.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Verma, Sandeep Kumar (Editor ), Das, Ashok Kumar (Associate Professor) (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Elsevier, 2023.
Colección:Comprehensive analytical chemistry ; 103
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a22000007i 4500
001 SCIDIR_on1408766500
003 OCoLC
005 20231120010759.0
006 m o d
007 cr cnu---unuuu
008 231109s2023 ne o 000 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d YDX  |d EBLCP  |d OCLCO 
019 |a 1408377700 
020 |a 0443221995  |q (electronic bk.) 
020 |a 9780443221996  |q (electronic bk.) 
020 |z 9780443221989 
020 |z 0443221987 
035 |a (OCoLC)1408766500  |z (OCoLC)1408377700 
050 4 |a QP517.B49 
082 0 4 |a 612.1111  |2 23/eng/20231109 
245 0 0 |a Bioconjugated materials.  |n Part 2,  |p Applications in drug delivery, vaccine formulations and important conjugates for cancer therapy /  |c editors, Sandeep Kumar Verma, Ashok Kumar Das. 
246 3 0 |a Applications in drug delivery, vaccine formulations and important conjugates for cancer therapy 
264 1 |a Amsterdam :  |b Elsevier,  |c 2023. 
300 |a 1 online resource (312 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Comprehensive analytical chemistry ;  |v 103 
520 |a Bioconjugated Materials Part 2, Volume 103 in the Comprehensive Analytical Chemistry series, highlights new advances in the field, with this new volume presenting interesting chapters on bioconjugated materials. Each chapter is written by an international board of authors. 
588 0 |a Print version record. 
505 0 |a Intro -- Bioconjugated Materials Part 2 Applications in Drug Delivery, Vaccine Formulations and Important Conjugates for Cancer Therapy -- Copyright -- Contents -- Contributors to Volume 103 -- About the editors -- Preface -- References -- Series editor's preface -- Chapter One: Multifunctional bioconjugates and their utilities -- 1. Introduction -- 2. Bioconjugation chemistry -- 3. Molecular conjugates -- 3.1. Carbohydrate oligonucleotides conjugates -- 3.2. Lipid oligonucleotides conjugates -- 3.3. Polymeric oligonucleotides conjugates -- 3.4. Antibody oligonucleotides conjugates 
505 8 |a 3.5. Aptamer oligonucleotide conjugates -- 3.6. Small molecule targeting conjugates -- 4. Bioconjugates as functional carriers -- 4.1. Polymer drug conjugates -- 5. Utility of nanobioconjugates in pharmacokinetics -- 6. Future perspectives of bioconjugation -- 7. Conclusions -- Acknowledgements -- References -- Chapter Two: Bioconjugated materials as potential vehicles for delivery of antibiotics/drugs -- 1. Introduction -- 2. Strategies for bioconjugate fabrication -- 2.1. Covalent conjugation -- 2.2. Noncovalent conjugation -- 3. Materials for antibiotics/drugs conjugation 
505 8 |a 3.1. Natural materials for antibiotics/drugs conjugation -- 3.1.1. Pectin -- 3.1.2. Dextran -- 3.1.3. Cellulose -- 3.1.4. Guar gum -- 3.1.5. Pullulan -- 3.1.6. Gum acacia -- 3.2. Synthetic materials for antibiotics/drugs conjugation -- 3.2.1. Polylactic acid (PLA) -- 3.2.2. Poly(lactic-co-glycolic acid) (PLGA) -- 3.2.3. Polycaprolactone -- 3.2.4. Poly(butylene succinate) -- 3.2.5. Polydioxanone (PDS) -- 4. Commercially available materials-conjugated antibiotics/drugs products -- 5. Conclusions and future directions -- Acknowledgements -- Conflicts of interest -- References 
505 8 |a Chapter Three: Bioconjugated materials in the development of subunit vaccines -- 1. Introduction -- 2. Recombinant protein and synthetic peptide-based subunit vaccines -- 2.1. Recombinant protein-based subunit vaccines -- 2.2. Synthetic peptide-based subunit vaccines -- 3. Bioconjugation methods in subunit vaccines -- 3.1. Staudinger ligation reaction -- 3.2. Diels-Alder reaction -- 3.3. N-Hydroxysuccinimide esters -- 3.4. Copper-catalysed alkyne-azide cycloaddition reaction -- 3.5. Strain promoted alkyne-azide cycloaddition -- 4. Bioconjugation materials in subunit vaccines 
505 8 |a 4.1. Polymeric materials as subunit vaccine adjuvants -- 4.1.1. Polysaccharides -- 4.1.1.1. Chitosan and its derivatives in subunit vaccines -- 4.1.1.2. Glucan-based subunit vaccines -- 4.1.1.3. Mannose-containing subunit vaccines -- 4.1.1.4. Insulin-containing subunit vaccines -- 4.1.2. Polyamino acids -- 4.1.3. Synthetic polymers -- 4.2. Lipids in subunit-based vaccines -- 4.2.1. Glycosphingolipids -- 4.2.2. Lipopolysaccharides -- 4.2.3. Lipoproteins and lipopeptides -- 5. Conclusions -- Conflicts of interest -- Funding -- References 
650 0 |a Bioconjugates. 
650 0 |a Pharmaceutical chemistry. 
650 2 |a Chemistry, Pharmaceutical  |0 (DNLM)D002626 
650 6 |a Bioconjugu�es.  |0 (CaQQLa)201-0322947 
650 6 |a Chimie pharmaceutique.  |0 (CaQQLa)201-0028674 
655 0 |a Electronic books. 
700 1 |a Verma, Sandeep Kumar,  |e editor. 
700 1 |a Das, Ashok Kumar  |c (Associate Professor),  |e editor. 
776 0 8 |i Print version:  |t Bioconjugated materials. Part 2, Applications in drug delivery, vaccine formulations and important conjugates for cancer therapy.  |d Amsterdam : Elsevier, 2023  |z 9780443221989  |w (OCoLC)1400077355 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/handbooks/0166526X/103  |z Texto completo